272
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Bothersome menopausal symptoms amongst postmenopausal Iranian women

ORCID Icon, , , , &
Pages 586-593 | Received 30 May 2018, Accepted 04 Jun 2018, Published online: 26 Aug 2018
 

Abstract

Objectives: This study was undertaken to determine the impact of menopause on middle-eastern women.

Methods: This was a cross-sectional study of 1520 women, aged 40–64 years, living in Sari, Northern Iran, recruited by multistage cluster sampling between October 2016 and April 2017. All women completed the Menopause Quality of Life Questionnaire (MENQOL) and Beck Depression Inventory-II (BDI-II).

Results: Of all the women, 54.5% were perimenopausal or postmenopausal. The prevalences of any vasomotor symptom (VMS) and moderate-severely bothersome VMS were greatest for postmenopausal women aged <55 years (66.4%, 95% confidence interval (CI) 59.9–72.3% and 13.5%, 95% CI 9.6–18.6%, respectively). Having moderate-severe VMS was associated with moderate-severe depressive symptoms (adjusted odds ratio (AOR) 2.9; 95% CI 1.6–5.2; p < 0.001). Symptoms of vulvovaginal atrophy (VVA) were reported by 41.1% (95% CI 37.4–45.0%) of perimenopausal and postmenopausal women, with 22.9% (95% CI 19.8–26.3%) reporting their symptoms as moderate-severely bothersome. In women with moderate-severe VMS, the proportion with both moderate-severe depressive symptoms and moderate-severe VVA symptoms (12.1%) was four times that in women with no or mild VMS (3.3%) (p < 0.001).

Conclusion: One in seven perimenopausal and postmenopausal women has moderate-severely bothersome VMS and few women receive appropriate therapy. The reporting of moderate-severe VMS should alert clinicians to the likelihood of significant concurrent VVA and depressive symptoms.

Acknowledgements

We would like to thank Miss Farahani, an employee of the Statistical Center of Mazandaran Budget and Planning Organization, who assisted us in cluster sampling by retrieving population data of the Sari city. We are also grateful to all women who provided data for this study.

Contributors

SRD, RJB, EF, and ZA designed the study. MA and MM collected and managed the data. EF analyzed the data and prepared the first draft of the publication and was responsible for revisions and ensuring overall integrity of the process. All co-authors (SRD, RJB, ZA, MM, and MA) approved the final version of the manuscript.

Conflict of interest

SRD has received honoraria from Lawley Pharmaceuticals, Pfizer Pharmaceuticals and Besins Healthcare and research funding from Lawley Pharmaceuticals. Other authors report no conflicts of interest.

Additional information

Funding

This work was supported by the Vice-Chancellor of Research, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran under grant number [IR.MAZUMS.REC.95.2344]; and National Health and Medical Research Council of Australia under grant number [1135843].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 277.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.